Dr. Ranjita Shegokar to deliver a lecture at RExPO25, the 4th International Conference on Systems Medicine and AI-driven Drug Repurposing, 24–26 Sep 2025, Barcelona, Spain. The event will focus on breakthroughs in network medicine, drug repurposing, and personalized therapeutics, featuring keynotes, workshops, and collaborative discussions.
The German Medical Award (GMA) is one of Germany’s most prestigious honors, recognizing medical practitioners, scientists, and industry initiatives for outstanding achievements in medicine and healthcare—particularly innovations that enhance patient care. Dr. Ranjita’s team at DiHeSys GmbH received the GMA 2025 award for a groundbreaking pharma project, “3D Printing for Precision Medicine – nanoparticle.” The project demonstrates how a nanoparticle-based approach, combined with advanced 2D printing technology, enables patient-specific precision dosing and optimized drug targeting—significantly enhancing treatment efficacy and advancing the future of personalized medicine.
During the 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences held from 31 August to 3 September 2025 in Copenhagen, Denmark, Dr. Ranjita Shegokar delivered a speech on “Advancements in 3D personalised medicines”. Her presentation aligned with the conference’s overarching theme, “Pharmacy Forward: Performance, Collaboration, and Health Transformation,” highlighting innovations and progress in industrial pharmaceutical sciences.
In Copenhagen, Denmark, Dr. Ranjita Shegokar was honoured with the 2025 FIP Distinguished Pharmaceutical Sciences Award by the International Pharmaceutical Federation (FIP) President, Paul Sinclair, in recognition of her outstanding global contributions to pharmaceutical science and innovation. The award highlights her pioneering research in drug–device combinations, nanomedicines, precision 2D/3D personalised medicines, and other areas of translational science. This prestigious honour celebrates her scientific leadership, innovation, and profound impact on advancing pharmaceutical technology worldwide.
Dr. Ranjita Shegokar delivered a plenary lecture on “Next Generation Drug Repurposing using 2D Printing and Nanoparticles” at RExPO25, the 4th International Conference on Systems Medicine, AI, and Drug Repurposing. Her talk was part of Session 4: Innovation in Drug Development and Repurposing, held from September 24–26, 2025, at the PRBB – Barcelona Biomedical Research Park in Barcelona, Spain. The REPO4EU consortium, formally known as Precision Drug Repurposing for Europe and the World, is a Horizon Europe-funded initiative advancing drug repurposing through systems medicine and artificial intelligence. Following the session, a panel discussion facilitated in-depth dialogue with the audience and experts, addressing current challenges, technological innovations, and collaborative strategies in drug repurposing to meet unmet medical needs.
The German Award for Sustainability (Deutscher Award für Nachhaltigkeitsprojekte) for 2025 was awarded to pharma initiative lead by Dr. Ranjita at DiHeSys on “2D Printed Personalized Medicines – Drug Life Cycle Management – Solution to Nanoparticles”, which promotes high drug dosing, a resource-efficient process, less medicinal/ medication waste, and sustainable approach for producing personalized medicines on demand, thereby contributing to a more sustainable healthcare system.
Dr. Ranjita Shegokar supported women empowerment initiatives in Kolkata, India, on the occasion of National Handloom Day (6 August 2025). The event was organized by Prayas and the Parichay Foundation in collaboration with the Indian Council for Cultural Relations (ICCR), Ministry of External Affairs, Government of India. It provided a platform to showcase and support skilled artisans, handloom workers, and promoters of ethnic textiles, celebrating traditional craftsmanship and empowering women in society. The celebration also featured a cultural dance program, highlighting traditional art forms and fostering community engagement.
While addressing the audience, Dr. Shegokar emphasized the role and contribution of women in society, the mindful use of textiles, the benefits of traditional cotton clothing, the issue of shopping-related waste in developed countries, and the need for scientific solutions to tackle garbage challenges. She underscored the shared responsibility, including governments, industry, and individuals, in promoting sustainable practices to protect the environment.
Pharma Times is the official magazine of the Indian Pharmaceutical Association (IPA). It publishes news, research updates, and reports on pharma industry trends and IPA activities. The magazine serves as a professional platform for thousands of pharmacists, scientists, and healthcare experts across India.
Dr. Ranjita Shegokar was a keynote speaker at the GMP-PHARMA Congress – 27th Conference & Expo held in Wiesbaden, Germany, April 2025. She delivered an insightful talk titled “Pharmaceutical Manufacturing Reinvented: The 3D Printing Process and Other New Technologies.” She highlighted how these advancements are shaping the future of personalized medicine and precision drug delivery. Her talk bridged the gap between scientific innovation and real-world application.
The Women in Pharma Award 2025, Ireland, honors the exceptional achievements of women in leadership and innovation within the pharmaceutical industry. Dr. Ranjita Shegokar served on the Jury Panel, helping select high-impact female professionals in pharma. Organized by the Business River Group, the award aims to inspire and empower the next generation of women leaders in the sector
Dr. Ranjita Shegokar delivered a talk in the 4th Global Conference on Pharmaceutics and Drug Delivery Systems, 2020, Italy. It brought together experts to discuss advancements in nanoformulations, targeted delivery, and biopharmaceuticals.
Dr. Ranjita Shegokar was honored with the Innovator of the Year award – 2019 by the International Business and Academic Excellence (IBAE) Awards. This prestigious recognition celebrated her outstanding contributions to pharmaceutical innovation in cancer targeting. The award acknowledged her as a leader driving transformation in pharma research and development.
Dr. Ranjita Shegokar was felicitated with the prestigious Aarya Award 2018 by Parichay Foundation in the 8th Edition Ceremony.
Parichay Foundation presents 8th Edition of AARYA Awards – The Truth One
At the prestigious India Excellence Awards held by the Blindwink Group in Bangalore, Dr. Ranjita Shegokar was honored with the title “Best Innovative Researcher of the Year”, recognizing her groundbreaking work in pharmaceutical nanomedicine.
Dr. Ranjita Shegokar served as a distinguished speaker at the Wahid Hasyim International Conference on Advanced Pharmaceutical Sciences (WHICAPS) held in Semarang, Indonesia, June 5–6, 2022, she delivered a keynote highlighting multiple approaches in advanced cancer therapy and handling cytostatic drugs. Her participation underscored her role in advancing multidisciplinary pharmaceutical innovation, particularly in the Asia–Europe context.
Dr. Ranjita Shegokar was awarded the prestigious German Academic Exchange Fellowship (DAAD), a highly competitive recognition given by the German Academic Exchange Service to outstanding researchers. This fellowship supported her advanced PhD and later as a postdoctoral researcher at the Free University of Berlin, enabling her to deepen her expertise in pharmaceutics, biopharmaceutics, and nanotechnology.